Developments in the pharmacotherapy of the overactive bladder.
about
TRPV1: on the road to pain reliefThe role of botulinum toxin A in treating neurogenic bladderTachykinins and their receptors: contributions to physiological control and the mechanisms of disease.Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement.
P2860
Developments in the pharmacotherapy of the overactive bladder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Developments in the pharmacotherapy of the overactive bladder.
@en
type
label
Developments in the pharmacotherapy of the overactive bladder.
@en
prefLabel
Developments in the pharmacotherapy of the overactive bladder.
@en
P1476
Developments in the pharmacotherapy of the overactive bladder.
@en
P2093
Neil McKay
P304
P356
10.1097/MOU.0B013E3281299033
P577
2007-07-01T00:00:00Z